News
Almac Clinical Services has completed a multi-million-dollar investment to enhance cold chain capabilities at its global ...
Körber’s Business Area Pharma now offers a standardized approach to connect systems and equipment to its market-leading PAS-X ...
The CDMO has increased its capacity by acquiring and installing a new, fully Annex 1 compliant, sterile filling line. As a ...
Pace Life Sciences LLC is remodeling and expanding its Salem, NH, site to establish a Center of Excellence for Aseptic ...
Axplora has announced a transformative €35 million ($41.2 million) expansion at its Farmabios site in Gropello Cairoli, Italy ...
Circio Holding ASA, a biotechnology company developing circular RNA technology for next generation nucleic acid medicine, has ...
Biosynth, a developer and supplier of critical raw materials and services for life sciences and diagnostics, has opened an expanded GMP bioconjugation facility at its existing Berlin site.
The Kiteworks research reveals that 27% of life organizations acknowledge that more than 30% of their AI-processed data ...
Hikma Pharmaceuticals will invest $1 billion by 2030 to further expand its US manufacturing and R&D capabilities.
Starton Therapeutics Inc., a clinical-stage biotechnology company, has entered into a collaboration agreement with Bend ...
It is the only ready-to-use liquid immunoglobulin therapy with (IgA) content and is set for commercialization in 2026.
BioMarin Pharmaceutical Inc. has completed the previously announced agreement to acquire Inozyme Pharma Inc. for $4.00 per ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results